Lilly launches $4.5bn medicine foundry to reshape drug production and clinical trials
Eli Lilly and Company has committed $4.5 billion to establish a revolutionary facility in Lebanon, Indiana—the Lilly Medicine Foundry. This one-of-a-kind site is set to ... Read More
Lilly to invest $2.1bn in two new pharma manufacturing plants in Indiana
Eli Lilly and Company (Lilly) said that it will invest $2.1 billion to build two new pharma manufacturing plants in Indiana, which will be located ... Read More
Lilly’s Covid-19 candidate bamlanivimab gets FDA’s EUA
The US Food and Drug Administration (FDA) has issued emergency use authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg, the investigational neutralizing antibody of Eli Lilly ... Read More
Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt
Eli Lilly and Company (Lilly) has signed a $375 million deal with the US government for the supply of 300,000 vials of bamlanivimab (LY-CoV555) 700mg, ... Read More
Lilly to build $470m pharma manufacturing plant in North Carolina
US pharma giant Eli Lilly and Company (Lilly) will build a new pharma manufacturing plant in North Carolina with an investment of more than $470 ... Read More